FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly a composition containing a lyophilised salt of vinflunine or vinorelbine stable at room temperature. A pharmaceutical composition containing a water-soluble salt of vinflunine or vinorelbine stable at room temperature where said salt is presented in the lyophilised form prepared in the presence at least of one carbohydrate of specific pH and relation of the water-soluble salt of vinflunine or vinorelbine and carbohydrate.
EFFECT: composition is stable.
9 cl, 2 dwg, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF VINFLUNINE INTENDED FOR PARENTERAL ADMINISTRATION, WAY OF RECEPTION AND APPLICATION | 2004 |
|
RU2362557C2 |
STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
CRYSTALLINE FORM OF VINFLUNINE DITARTRATE | 2006 |
|
RU2426735C2 |
STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
FLUORINATED CATHARANTINE DERIVATIVES, THEIR OBTAINING AND APPLICATION AS PRECURSORS OF DIMERIC VINCA ALKALOIDS | 2007 |
|
RU2448957C2 |
ANHYDROUS CRYSTALLINE VINFLUNINE SALTS, METHOD FOR PREPARING AND USING THEM AS DRUG, AND METHOD FOR PURIFYING VINFLUNINE | 2008 |
|
RU2456291C2 |
STABLE SOLID DISPERSION OF VINCA ALKALOID DERIVATIVE AND METHOD FOR PRODUCING THEREOF | 2005 |
|
RU2412687C2 |
VINORELBINE MONOTARTRATE AND ITS PHARMACEUTICAL APPLICATION | 2016 |
|
RU2730521C2 |
PREPARATIONS | 2006 |
|
RU2429845C2 |
LYOPHILIZED PHARMACEUTICAL COMPOSITIONS FOR VAGINAL DELIVERY | 2017 |
|
RU2753864C2 |
Authors
Dates
2012-05-10—Published
2007-12-28—Filed